Research progress and prospect of sentinel lymph node mapping in endometrial carcinoma

鲁圆圆; 杨　帆; 郑　莹

doi:10.19401/j.cnki.1007-3639.2021.10.011

您当前的位置：

首页 >

文章列表页 >

Research progress and prospect of sentinel lymph node mapping in endometrial carcinoma

更新时间：2025-12-31

- Research progress and prospect of sentinel lymph node mapping in endometrial carcinoma
- China Oncology Vol. 31, Issue 10, Pages: 944-948(2021)
- 作者机构：
  
  四川大学华西第二医院妇科，出生缺陷与相关妇儿疾病教育部重点实验室,四川,成都,610041
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2021.10.011
  CLC：
- Published Online：10 November 2021，
  
  Published：10 November 2021
- 稿件说明：
移动端阅览
鲁圆圆, 杨　帆, 郑　莹. 子宫内膜癌前哨淋巴结应用的研究进展与展望[J]. 中国癌症杂志, 2021, 31(10): 944-948.

鲁圆圆, 杨　帆, 郑　莹. Research progress and prospect of sentinel lymph node mapping in endometrial carcinoma[J]. China Oncology, 2021, 31(10): 944-948.
鲁圆圆, 杨　帆, 郑　莹. 子宫内膜癌前哨淋巴结应用的研究进展与展望[J]. 中国癌症杂志, 2021, 31(10): 944-948. DOI： 10.19401/j.cnki.1007-3639.2021.10.011.

鲁圆圆, 杨　帆, 郑　莹. Research progress and prospect of sentinel lymph node mapping in endometrial carcinoma[J]. China Oncology, 2021, 31(10): 944-948. DOI： 10.19401/j.cnki.1007-3639.2021.10.011.

摘要

前哨淋巴结（sentinel lymph node，SLN）检测为子宫内膜癌患者的精准淋巴结切除提供了选择，极具应用前景，但仍有部分问题和争议亟待解决，如SLN检测在高危患者中的标准临床应用规范、SLN最佳算法、评估SLN的最佳方式、低体积转移的临床意义，均值得探究。目前子宫颈注射吲哚菁绿为最常用的示踪方法，病理学超分期可提高对低体积转移的检出率，但病理学超分期操作流程、应用指征及低体积转移的临床管理需进一步规范。此外，高危型子宫内膜癌并非SLN检测的绝对禁忌证，但此类患者行SLN检测的标准临床应用规范有待进一步研究。现就近年来子宫内膜癌SLN检测研究现状及进展进行综述。

Abstract

Sentinel lymph node (SLN) mapping has been proposed as a more “targeted” alternative for accurate lymph node resection in endometrial cancer (EC). However

there are still some problems and disputes to be resolved. For example

the standard clinical application of SLN mapping in high-risk patients

the optimal SLN algorithm

the optimal approach to evaluate SLN and the clinical significance of low volume metastasis (LVM) are worth exploring. At present

the cervical indocyanine green injection is the most commonly used tracer method

and the detection rate of LVM can be improved by ultrastaging. However

the procedures and indications of ultrastaging and clinical management of LVM need to be further standardized. In addition

high-risk EC is not an absolute contraindication for SLN mapping

however

the standard clinical application of SLN mapping in such patients needs further clinical study. This article reviewed the research status and progress of SLN mapping in EC in recent years.

关键词

Keywords

references

Views

3532

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Axillary management after neoadjuvant therapy for breast cancer and optimization of sentinel lymph node diagnosis and treatment

Progress in treatment of gynecological cancer in 2023

The latest progress and prospect of gynecological tumor treatment at 2023 ESMO

Mechanism of METTL14-mediated ERα m6A regulation of endometrial cancer metastasis

Progress in diagnosis and treatment of gynecological tumors in 2022

Related Author

Yanling ZHENG

Xiaoyan XIE

Jiaping LI

Jiaqian ZHONG

Hao WEN

Xiaohua WU

Jun ZHU

Qinhao GUO

Related Institution

Department of Ultrasound, First Affiliated Hospital of Sun Yat-sen University

Department of Gynecological Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Hyperbaric Oxygen, Qinghai Provincial People’s Hospital

Department of Gynecology, Qinghai Provincial People’s Hospital

Department of Cadres Health Care, Qinghai Provincial People’s Hospital

AI问答

⁰